Towards Better Delivery of Cannabidiol (CBD)

Towards Better Delivery of Cannabidiol (CBD)

Cannabidiol (CBD) has substantial therapeutic potential, but its development as an effective drug by the pharmaceutical industry is hindered by intrinsic characteristics such as low bioavailability, low water solubility, and variable pharmacokinetic profiles. Importantly, lack of patentability of th...

Full description

Bibliographic Details
Main Authors: Sophie Anne Millar, Ryan Francis Maguire, Andrew Stephen Yates, Saoirse Elizabeth O’Sullivan
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Pharmaceuticals
Subjects:
cannabidiol
CBD
formulation
clinical development
Online Access:https://www.mdpi.com/1424-8247/13/9/219

Similar Items

Similar Items